Vaccine News and Research

Latest Vaccine News and Research

FDA expands use of influenza vaccine FluMist

The U.S. Food and Drug Administration has approved expanding the population for use of the nasal influenza vaccine FluMist to include children between the ages of 2 and 5.

20 Sep 2007

Cases of invasive pneumococcal disease in children reduced

The number of cases of invasive pneumococcal disease (IPD) in children has fallen since the introduction of a new vaccine a year ago. Enhanced surveillance by the UK's Health Protection Agency has shown that cases of IPD caused by the seven major types of the pneumococcus bacteria which the new pneumococcal conjugate vaccine (PCV) protects against have gone down by almost 50%.

20 Sep 2007

Modelling data reveals cost effectiveness of HPV vaccine

New modelling research presented at the Health Protection Agency's annual conference will show that up to 70% of cases of cervical cancer and 95% of cases of genital warts in men and women could be prevented by the introduction of human papilloma virus (HPV) vaccination into the UK 's national immunisation programme. This is in addition to the cancer cases already prevented by the NHS cervical screening programme.

20 Sep 2007

Cervical cancer screening: Too many are left unprotected

The decline in cervical cancer is a success story of cancer research.

20 Sep 2007

Childhood vaccination for the rubella virus may protect adult eyes

Childhood vaccination for the rubella virus may have also almost entirely eliminated an inflammatory eye disease from the U.S.-born population, according to a study by researchers at the University of Illinois at Chicago.

20 Sep 2007

Gates Foundation digs down deep for TB

The fight against the global tuberculosis (TB) epidemic has received a huge boost in the form of a $280 million grant from the Bill & Melinda Gates Foundation.

20 Sep 2007

Possible hepatitis C vaccine

The British Midlands Development Corporation has announced that the University of Nottingham in the British Midlands has released a statement promoting the development of a possible Hepatitis C Vaccine.

18 Sep 2007

Sanofi Pasteur's new H5N1 vaccine shows promise

Sanofi pasteur, the vaccines division of sanofi-aventis Group, has announced data showing that its new investigational H5N1 pandemic influenza vaccine containing a proprietary adjuvant achieved a high immune response at the lowest dose of H5N1 antigen reported to date.

18 Sep 2007

Chronic infection persists by targeting stromal cell network in lymphoid organs

One of the biggest challenges to treating infectious diseases and developing preventive vaccines is the ability of many chronic infections to suppress the immune T-cell response over time.

18 Sep 2007

Australian doctor awarded for uncovering smallpox bioterrorism risk

A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.

18 Sep 2007

New guidelines to diagnose Alzheimer's disease

Physicians may be able to detect and treat Alzheimer's Disease (AD) in its earliest stages, when patients are experiencing only mild degrees of cognitive impairment, thanks to new diagnostic criteria proposed by an international group of researchers.

18 Sep 2007

Nanoparticle that delivers vaccines more effectively

Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.

18 Sep 2007

HPV infection and head and neck cancer

The human papillomavirus (HPV) has been implicated as a cause of cervical cancer in women, but there's another devastating form of cancer also linked to HPV infection - head and neck cancer - and almost no one is talking about it.

18 Sep 2007

LL37 peptide provides a new potential target for autoimmune disease

A human peptide that acts as a natural antibiotic against invading microbes can also bind to the body's own DNA and trigger an immune response in the absence of an infection, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in an early online publication in Nature.

17 Sep 2007